AI-designed nanoparticles stabilize mRNA vaccines at high temperatures, Nature Biotech reports
emmanuelvivier · x · 2026-10-09
A Nature Biotechnology study uses AI to design nanoparticles that stabilize mRNA vaccines at elevated temperatures, potentially reducing cold-chain dependence.
The authors caution these are preclinical results, not yet a clinical solution.
Related event: AI-designed nanoparticles keep mRNA vaccines stable at room temperature(2 posts)→
More from Research
- Multi-agent framework CORAL presented at COLM, tops 1.1K GitHub stars — pliang279 · 2026-10-09
- LLM judges of AI-scientist novelty flip on tiny prompt tweaks, AI2 finds — TuhinChakr · 2026-10-09
- TritonRL: an 8B RL-trained model matches 100B+ frontier models on Triton kernel generation — allenainie · 2026-10-09
- LLM agent polarization study from Tsinghua-UChicago team published in Nature Communications — profjamesevans · 2026-10-09
- Forced contact moves LLM agent opinions just 2%, polarization study finds — profjamesevans · 2026-10-09
- LLM agents build human-like social networks — and polarize anyway — profjamesevans · 2026-10-09